US Lawsuits Challenge Marketing of Toddler Milks Over Health Concerns | Ukraine news

In the United States, a growing controversy surrounds the marketing of so-called “toddler milks” – products marketed for children aged 1 to 3. Parents are filing lawsuits, arguing that these drinks are not a necessary part of the diet and can cause harm due to excessive sugar and manipulative packaging.

The American Academy of Pediatrics emphasizes that after age one, children typically only need regular milk, which is significantly cheaper and nutritionally superior to toddler drinks. Such beverages often complicate diets and increase family costs.

While the industry and experts discuss regulatory frameworks, other products are appearing on the market that do not fall under the same standards of control. Experts warn that they may be nutritionally unnecessary and even harmful due to excessive sugar.

“Cow’s milk is nutritionally sufficient for almost all children after 12 months and costs up to 30 times less than these toddler milks.”

Lawsuits and Criticism of Toddler Milks’ Marketing Practices

One of the most high-profile cases involved a lawsuit by Damary Santana against Abbott Nutrition, the maker of the Similac line. The suit alleges that bright colors and marketing promises on the packaging mislead parents and push them toward buying products that are not needed for children’s development.

“They stood out with bright colors, particularly red, which caught my attention.”

“I could have spent these funds on other needs, such as clothing and diapers.”

The suit was filed by attorney Andrew Rainer, who heads the Center for Public Health at Northeastern University School of Law. He emphasizes that toddler milks are expensive, nutritionally unwarranted, and may be harmful due to added sugar.

“Toddler milks are expensive, nutritionally unnecessary and can be harmful due to added sugar.”

Abbott Nutrition, responsible for the Go & Grow line, says that their children’s products are properly labeled and that their claims are backed by data. In prior cases, similar suits have often been dismissed or partially dismissed.

“Our children’s foods are properly labeled, and our claims are supported by data.”

Market participants and experts also point to international norms: WHO does not allow marketing toddler milks by analogy with codes governing artificial infant formula, but the United States does not necessarily adhere to the same restrictions. Public-interest groups and regulatory bodies discuss whether tighter oversight of advertising and labeling is needed to avoid confusion among parents.

“If you are producing formula for children over 12 months, there are no such restrictions.”

Experts note that the topic of toddler milks is only beginning to take shape in the judicial and regulatory arena. They call for greater labeling transparency, research into the impact of such products on children’s nutritional needs, and consideration of stricter advertising rules to reduce pressure on parents.

“There is no reason for the existence of this product category.”